# Improving Beta Cell Function in Mexican American Women With Prediabetes

> **NCT02488057** · PHASE4 · COMPLETED · sponsor: **Ohio State University** · enrollment: 360 (actual)

## Conditions studied

- Pre-Diabetes

## Interventions

- **DRUG:** Liraglutide
- **BEHAVIORAL:** Weight loss

## Key facts

- **NCT ID:** NCT02488057
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488057, "Improving Beta Cell Function in Mexican American Women With Prediabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02488057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*